NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe ...

NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe CAMBRIDGE, MA / ACCESS Newswire / February 17, 2026 / Modern ...

Under the Trump administration, the government has rescinded research funding, changed vaccine recommendations, and refused ...

As Michigan sees growing rates of COVID-19 and high rates of influenza, a national poll led by the University of Michigan has found that 42% of individuals over 50 have not received a shot for either ...

The anti-science, anti-medicine mindset of the nutso Health and Human Services Secretary Robert F. Kennedy Jr. is killing ...

US mRNA specialist Moderna today announced that the European Commission (EC) has granted marketing authorization for mNEXSPIKE (mRNA-1283), a new COVID vaccine, for active immunization to prevent ...

Their worst fears are starting to come true, according to executives and investors involved with companies that develop and sell vaccines and the mRNA technology that is best known for the Covid ...

The anti-science, anti-medicine mindset of the nutso Health and Human Services Secretary Robert F. Kennedy Jr. is killing ...

In a major blow to vaccine development, the FDA said it will not review Moderna’s application for the first mRNA-based flu shot.

The Swiss government must disclose contracts concluded with pharmaceutical companies for the procurement of Covid vaccines.

Moderna, Inc. MRNA shares are trading higher Tuesday after the company announced European Commission marketing authorization for its COVID-19 vaccine, mNEXSPIKE. Moderna stock is showing upward ...

The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is “part of a disturbing pattern” of moving regulatory goalposts, according to Clay Alspach, executive director of the Alliance for mRNA ...